Status:
UNKNOWN
Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer
Lead Sponsor:
Peking University First Hospital
Collaborating Sponsors:
YiZhou International Cancer Hospital
Conditions:
Proton Therapy
Immunotherapy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this research study is to compare the effects (good and bad) on subjects and their cancer using proton radiation therapy in combination with immunotherapy(ie. Programmed cell death prot...
Detailed Description
As is known to all, the main treatment method for metastatic tumors is systemic chemotherapy and radiotherapy is merely for the purpose of palliative treatment. Recent studies have shown that tumors w...
Eligibility Criteria
Inclusion
- Pathologically confirmed Unspecified Adult Solid Tumor
- Multiple metastatic tumors
- Intending to be treated with proton beam and immunotherapy
- Age ≥ 18 years old
- KPS≥70
- Signed written informed consent.
Exclusion
- Pregnant or breastfeeding woman
- Patient under guardianship or tutorship
- Patients or legal guardians who are unable to understand informed consent document
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03765190
Start Date
January 1 2019
End Date
December 1 2022
Last Update
December 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.